申请人:[en]INNATE PHARMA
公开号:WO2022112356A1
公开(公告)日:2022-06-02
The invention relates to antigen-binding proteins capable of binding to Nectin-4 polypeptides conjugated to chemotherapeutic agents, for use in increasing sensitivity of tumors to the chemotherapeutic agents and for use in the treatment of cancers characterized by Nectin-4- expressing tumor cells.